Docosahexaenoic acid and smoking-related chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 6, 1999, Pages 1780-1785

  Shahar, Eyal ^a,b,c   Boland, Lori L ^a,b   Folsom, Aaron R ^a,b   Tockman, Melvyn S ^a,b   McGovern, Paul G ^a,b   Eckfeldt, John H ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL FEATURE; FATTY ACID BLOOD LEVEL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MODEL; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPIROMETRY;

EID: 0032989152     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.6.9810068     Document Type: Article

References (35)

1. 1. Weber, P. C. 1988. Membrane phospholipid modification by dietary n-3 fatty acids: effects on eicosanoid formation and cell function. Prog. Clin. Biol. Res. 282:263-274.
2. 2. Willis, A. L. 1981. Nutritional and pharmacological factors in eicosanoid biology. Nutr. Rev. 39:289-301.
3. 3. Lee, T. H., R. L. Hoover, J. D. Williams, R. I. Sperling, J. Ravalese III, B. W. Spur, D. R. Robinson, E. J. Corey, R. A. Lewis, and K. F. Austen. 1985. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Engl. J. Med. 312:1217-1224.
4. 4. Payan, D. G., M. Y. S. Wong, T. Chernov-Rogan, F. H. Valone, W. C. Pickett, V. A. Blake, W. M. Gold, and E. J. Goetzl. 1986. Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid. J. Clin. Immunol. 6:402-410.
5. 5. Schmidt, E. B., K. Varming, J. O. Pedersen, H. H. Lervang, N. Grunnet, C. Jersild, and J. Dyerberg. 1992. Long-term supplementation with n-3 fatty acids: II. Effect on neutrophil and monocyte chemotaxis. Scand. J. Clin. Lab. Invest. 52:229-236.
6. 4 in human granulocytes. Biochim. Biophys. Acta. 1166:20-24.
7. 7. Fisher, M., P. H. Levine, B. H. Weiner, M. H. Johnson, E. M. Doyle, P. A. Ellis, and J. J. Hoogasian. 1990. Dietary n-3 fatty acid supplementation reduces superoxide production and chemiluminescence in a monocyte-enriched preparation of leukocytes. Am. J. Clin. Nutr. 51: 804-808.
8. 8. Endres, S., R. Ghorbani, V. E. Kelley, K. Georgilis, G. Lonnemann, J. W. M. van der Meer, J. G. Cannon, T. S. Rogers, M. S. Klempner, P. C. Weber, E. J. Schaefer, S. M. Wolff, and C. A. Dinarello. 1989. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N. Engl. J. Med. 320:265-271.
9. 9. Sperling, R. I., J. L. Robin, K. A. Kylander, T. H. Lee, R. A. Lewis, and K. F. Austen. 1987. The effects of n-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes. J. Immunol. 139:4186-4191.
10. 10. Kaminski, W. E., E. Jendraschak, R. Kiefl, and C. von Schacky. 1993. Dietary w-3 fatty acids lower levels of platelet-derived growth factor mRNA in human mononuclear cells. Blood 81:1871-1879.
11. 11. Kremer, J. M., W. Jubiz, A. Michalek, R. I. Rynes, L. E. Bartholomew, J. Bigaouette, M. Timchalk, D. Beeler, and L. Lininger. 1987. Fish-oil fatty acid supplementation in active rheumatoid arthritis. Ann. Intern. Med. 106:497-503.
12. 12. Stenson, W. F., D. Cort, J. Rodgers, R. Burakoff, K. DeSchryver-Kecskemeti, T. L. Gramlich, and W. Beeken. 1992. Dietary supplementation with fish oil in ulcerative colitis. Ann. Intern. Med. 116:609-614.
13. 13. Shahar, E., A. R. Folsom, S. L. Melnick, M. S. Tockman, G. W. Comstock, V. Gennaro, M. W. Higgins, P. D. Sorlie, W. J. Ko, and M. Szklo. 1994. Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. N. Engl. J. Med. 331: 228-233.
14. 14. Sharp, D. S., B. L. Rodriguez, E. Shahar, L. J. Hwang, and C. M. Burchfiel. 1994. Fish consumption may limit the damage of smoking on the lung. Am. J. Respir. Crit. Care Med. 150:983-987.
15. 15. The ARIC Investigators. 1989. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am. J. Epidemiol. 129:687-702.
16. 16. Ma, J., A. R. Folsom, E. Shahar, and J. H. Eckfeldt. 1995. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. Am. J. Clin. Nutr. 62:564-571.
17. 17. Shahar, E., A. R. Folsom, and R. Jackson. 1996. The effect of nonresponse on prevalence estimates for a referent population: insights from a population-based cohort study. Ann. Epidemiol. 6:498-506.
18. 18. Morrison, W. R., and L. M. Smith. 1964. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J. Lipid. Res. 5:600-608.
19. 19. Ma, J., A. R. Folsom, J. H. Eckfeldt, L. Lewis, L. E. Chambless, and the Atherosclerosis Risk in Communities (ARIC) Study Investigators. 1995. Short- and long-term repeatability of fatty acid composition of human plasma phospholipids and cholesterol esters. Am. J. Clin. Nutr. 62:572-578.
20. 20. Ferris, B. G. 1978. Epidemiology standardization project (American Thoracic Society). Am. Rev. Respir. Dis. 118(Suppl.):1-120.
21. 21. American Thoracic Society. 1979. Snowbird workshop on standardization of spirometry. Am. Rev. Respir. Dis. 119:831-838.
22. 22. Crapo, R. O., A. H. Morris, and R. M. Gardner. 1981. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am. Rev. Respir. Dis. 123:659-664.
23. 23. American Thoracic Society. 1991. Lung function testing: selection of reference values and interpretative strategies. Am. Rev. Respir. Dis. 144: 1202-1218.
24. 24. Niewochner, D. E. 1988. Cigarette smoking, lung inflammation, and the development of emphysema. J. Lab. Clin. Med. 111:15-27.
25. 25. Hoogsteden, H. C., and P. T. W. van Hal. 1991. Mediators of the induction of nonallergic pulmonary inflammation. In M. A. Bray and W. H. Anderson, editors. Mediators of Pulmonary Inflammation. Marcel Dekker, New York. 185-277. Lung Biology in Health and Disease, Vol. 54.
26. 26. MacNee, W., B. Wiggs, A. S. Belzberg, and J. C. Hogg. 1989. The effect of cigarette smoking on neutrophil kinetics in human lungs. N. Engl. J. Med. 321:924-928.
27. 27. Zakrzewski, J. T., N. C. Barnes, P. J. Piper, and J. F. Costello. 1987. The detection of 5-lipoxygenase and cyclo-oxygenase products in sputum of patients with chronic bronchitis and bronchiectasis. Prostaglandins 33:663-674.
28. 28. Hoidal, J. R., R. B. Fox, P. A. LeMarbe, R. Perri, and J. E. Repine. 1981. Altered oxidative metabolic responses in vitro of alveolar macrophages from asymptomatic cigarette smokers. Am. Rev. Respir. Dis. 123:85-89.
29. 29. Janoff, A. 1983. Biochemical links between cigarette smoking and pulmonary emphysema. J. Appl. Physiol. 55:285-293.
30. 30. Shaw, R. J. 1991. The role of lung macrophages at the interface between chronic inflammation and fibrosis. Respir. Med. 85:267-273.
31. 31. Baybutt, R. C., J. E. Smith, and Y.-Y. Yeh. 1993. The effects of dietary fish oil on alveolar type II cell fatty acids and lung surfactant phospholipids. Lipids 28:167-172.
32. 32. Mancuso, P., J. Whelan, S. J. DeMichele, C. C. Snider, J. A. Guszcza, and M. D. Karlstad. 1997. Dietary fish oil and fish and borage oil suppress intrapulmonary proinflammatory eicosanoid biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxic rats. Crit. Care Med. 25:1198-1206.
33. 33. Kobayashi, J., S. Yokoyama, and S. Kitamura. 1995. Eicosapentaenoic acid modulates arachidonic acid metabolism in rat alveolar macrophages. Prostaglandins Leukot. Essent. Fatty Acids 52:259-262.
34. 34. Breil, I., T. Koch, A. Heller, E. Schlotzer, A. Grunert, K. van Ackern, and H. Neuhof. 1996. Alteration of n-3 fatty acid composition in lung tissue after short-term infusion of fish oil emulsion attenuates inflammatory vascular reaction. Crit. Care Med. 24:1893-1902.
35. 35. Knapp, H. R. 1995. Omega-3 fatty acids in respiratory diseases: a review. J. Am. Coll. Nutr. 14:18-23.